Codexis

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Codexis and other ETFs, options, and stocks.

About CDXS

Codexis, Inc. is an enzyme engineering company, which engages in the development and sale of therapeutics. It operates through the Performance Enzymes and Novel Biotherapeutics segments.

CEO

Stephen George Dilly

CEOStephen George Dilly

Employees

188

Employees188

Headquarters

Redwood City, California

HeadquartersRedwood City, California

Founded

2002

Founded2002

Employees

188

Employees188

CDXS Key Statistics

Market cap

199.24M

Market cap199.24M

Price-Earnings ratio

-2.43

Price-Earnings ratio-2.43

Dividend yield

—

Dividend yield—

Average volume

970.49K

Average volume970.49K

High today

$2.51

High today$2.51

Low today

$2.39

Low today$2.39

Open price

$2.44

Open price$2.44

Volume

628.54K

Volume628.54K

52 Week high

$6.08

52 Week high$6.08

52 Week low

$1.90

52 Week low$1.90

CDXS News

TipRanks 5h

Major Shareholder Makes Bold Move with Codexis Stock Purchase

New insider activity at Codexis ( (CDXS) ) has taken place on July 1, 2025. Don’t Miss TipRanks’ Half-Year Sale Take advantage of TipRanks Premium at 50% off!...

Analyst ratings

71%

of 7 ratings

Buy

71.4%

Hold

28.6%

Sell

People also own

Based on the portfolios of people who own CDXS. This list is generated using Robinhood data, and it’s not a recommendation.